屯門醫院是新界屯門區一所公營地區全科醫院，提供24小時急症服務、第二及第三層專科醫療服務。醫院自1990年代啟用，為屯門區及元朗區近百萬人口提供服務。

During the past decade, Tuen Mun Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Tuen Mun Hospital" are "Active Systemic Lupus Erythematosus" (1 trials), "Liver Fibrosis Due to Chronic Hepatitis B Infection" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Systemic Lupus Erythematosus (SLE)" (1 trials). Many other conditions were trialed in "Tuen Mun Hospital" in a lesser frequency.

Most popular intervention types in "Tuen Mun Hospital" are "Drug" (4 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Best Supportive Care (BSC)" (1 trials), "Efavaleukin Alfa" (1 trials), "Entecavir" (1 trials) and "FG-3019" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tuen Mun Hospital" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Tuen Mun Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Tuen Mun Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tuen Mun Hospital, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".